A new economic model in the Canadian Journal of Cardiology identifies three critical benefits of integrating pharmacists and nurse practitioners into heart failure medication management. First, patient survival extends when clinical pharmacists and nurse practitioners actively manage medications, addressing one of the most important outcome measures in chronic disease care.
Second, hospitalisation duration and readmissions—major drivers of healthcare costs and patient burden—are significantly reduced through interprofessional medication management. Third, the cost-effectiveness data supports scaling these team-based models globally, making them accessible to diverse healthcare systems.
For healthcare leaders and clinicians, these findings provide clear evidence that expanding the clinical team beyond physicians improves care quality while supporting financial sustainability. The interprofessional approach addresses long-standing challenges in medication adherence and optimisation that affect millions of heart failure patients worldwide.
Was this article helpful?
